Literature DB >> 24964054

Insights into drug delivery across the nail plate barrier.

Manish V Saner1, Abhijeet D Kulkarni, Chandrakantsing V Pardeshi.   

Abstract

Topical therapy is at the forefront in treating nail ailments (especially onychomycosis and nail psoriasis) due to its local effects, which circumvents systemic adverse events, improves patient compliance and reduces treatment cost. However, the success of topical therapy has been hindered due to poor penetration of topical therapeutics across densely keratinized nail plate barrier. For effective topical therapy across nail plate, ungual drug permeation must be enhanced. Present review is designed to provide an insight into prime aspects of transungual drug delivery viz. nail structure and physiology, various onychopathies, techniques of nail permeation enhancement and in vitro models for trans-nail drug permeation studies. Updated list of drug molecules studied across the nail plate and key commercial products have been furnished with sufficient depth. Patents pertinent to, and current clinical status of transungual drug delivery have also been comprehensively reviewed. This is the first systematic critique encompassing the detailed aspects of transungual drug delivery. In our opinion, transungual drug delivery is a promising avenue for researchers to develop novel formulations, augmenting pharmaceutical industries to commercialize the products for nail disorders.

Entities:  

Keywords:  Nail permeation; nail plate; onychomycosis; penetration enhancement; topical therapy; transungual drug delivery

Mesh:

Year:  2014        PMID: 24964054     DOI: 10.3109/1061186X.2014.929138

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  14 in total

Review 1.  Transungual permeation: current insights.

Authors:  Ronak S Bhuptani; Ketaki M Deshpande; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

2.  Iontophoresis application for drug delivery in high resistivity membranes: nails and teeth.

Authors:  Jayanaraian F Martins Andrade; Thamires da Cunha Miranda; Marcílio Cunha-Filho; Stephânia Fleury Taveira; Guilherme M Gelfuso; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2022-10-08       Impact factor: 5.671

3.  Human nail plate modifications induced by onychomycosis: implications for topical therapy.

Authors:  A Baraldi; S A Jones; S Guesné; M J Traynor; W J McAuley; M B Brown; S Murdan
Journal:  Pharm Res       Date:  2014-11-22       Impact factor: 4.200

4.  An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.

Authors:  W J McAuley; S A Jones; M J Traynor; S Guesné; S Murdan; M B Brown
Journal:  Eur J Pharm Biopharm       Date:  2016-03-08       Impact factor: 5.571

Review 5.  A Compendium of Intralesional Therapies in Nail Disorders.

Authors:  Chander Grover; Shikha Bansal
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

6.  The use of urea for the treatment of onychomycosis: a systematic review.

Authors:  S Dars; H A Banwell; L Matricciani
Journal:  J Foot Ankle Res       Date:  2019-04-11       Impact factor: 2.303

Review 7.  Novel Drug Delivery Strategies for the Treatment of Onychomycosis.

Authors:  Rupinder K Dhamoon; Harvinder Popli; Madhu Gupta
Journal:  Pharm Nanotechnol       Date:  2019

8.  Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation.

Authors:  Atiya Rahman; Mohd Aqil; Abdul Ahad; Syed Sarim Imam; Abdul Qadir; Asgar Ali
Journal:  3 Biotech       Date:  2021-06-11       Impact factor: 2.893

9.  Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer.

Authors:  Elena Cutrín-Gómez; Soledad Anguiano-Igea; M Begoña Delgado-Charro; José Luis Gómez-Amoza; Francisco J Otero-Espinar
Journal:  Pharmaceutics       Date:  2018-09-11       Impact factor: 6.321

10.  NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile.

Authors:  Derry K Mercer; Jennifer C Robertson; Lorna Miller; Colin S Stewart; Deborah A O'Neil
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.